ArticleAnalytical and bioanalytical chemistry2025
LC-MS/MS quantification of bacterial and fungal signal peptides via direct injection: a case study of cross-kingdom communication.
Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacteria and yeast use secreted signal peptides, also known as pheromones, for cell-cell communication within their respective species. Recently, genetic modification has allowed for the extension and exploitation of this type of communication, to communication between organisms from different species and even from different kingdoms. This innovative approach is intended to allow for the large-scale production of specific compounds for applications in medicine and biotechnology while producing reduced amounts of by-products. Until now, the detection of signal peptides, which are often short-lived and only present in small amounts, is usually qualitative, non-selective, and time-consuming and/or requires the presence of additional cell types. Here, an ESI-LC-MS/MS method for the specific quantification of signal peptides from yeast (α- and P-factor) and bacteria (CSF) using a TSKgel column operating under HILIC conditions has been demonstrated. The influence of different matrices, their adsorption behavior, and their stability were investigated. In matrix, LOQs of 0.05 µM, 0.03 µM, and 0.02 µM were obtained for CSF, α-factor, and P-factor, respectively. Subsequently, the developed method was applied to the detection of yeast- and bacteria-specific peptides secreted by genetically modified yeasts. It could be demonstrated that under overexpressing conditions, α-factor and P-factor concentrations of 1 µM were measured, while for CSF concentrations as high as 2.5 µM was reached. Finally, the established method permits the simultaneous, quantitative detection of signal peptides in different matrices and without pre-concentration in near-real time, thus advancing the possibility of tracking cross-kingdom communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.